Across
- 3. ‘Largest’ environmental risk factor for PsA?
- 5. The main resident cells in the synovium
- 7. Anti-IL23 biologic
- 8. These cells build more bone in PsA
- 11. A T cell therapy licenced in 2016 by the EMA for PsA “abatacept”
- 12. Email traps the small molecular inhibitor, strangely
- 13. North of England city provides a score for 15 down
- 18. Relating to PsO, the HR for PsA is highest when this area is involved
- 19. These proteases are important in matrix degradation and involve a metal
Down
- 1. Heinrich _______, described this phenomenon; when deep it may cause PsA
- 2. This condition is thought to be a feature of PsA circa 50% of cases, but has a prevalence of only 5% of controls
- 4. Prevalence of HLA B27 in Ireland (%)
- 6. Sausage Toe
- 9. Bug bear-ing psoriasis?
- 10. A disease activity score for PsA, initially
- 14. A surgical cure for psoriasis?
- 15. Inflammation where bone meets tendon
- 16. Erosive, disco-vertebral lesion
- 17. This ocular pathology occurs in 7% of PsA patients
